Aspen Pharmacare Holdings Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a APNHF research report →
About the company
Operating worldwide, Aspen Pharmacare Holdings Limited, together with its subsidiaries, focuses on the development, production, and global distribution of specialized and branded pharmaceutical products. The company's business activities are structured into two main divisions: Commercial Pharmaceuticals and Manufacturing. Under its Anaesthetics portfolio, Aspen offers diverse products such as general anesthetics, muscle relaxants, and topical agents.
- CEO
- Stephen Bradley Saad
- IPO
- 2010
- Employees
- 8,867
- HQ
- Durban, ZA
Price Chart
- Market Cap
- $3.86B
- P/E
- -35.08
- P/S
- 1.82
- P/B
- 0.86
- EV/EBITDA
- 53.94
- Div Yield
- 1.34%
- Gross Margin
- 41.91%
- Op Margin
- 16.01%
- Net Margin
- -5.19%
- ROE
- -2.41%
- ROIC
- 5.32%
- Revenue
- $43.36B · -3.00%
- Net Income
- $-1,083,000,000 · -124.59%
- EPS
- $-2.44 · -124.62%
- Op Income
- $1.44B
- FCF YoY
- -84.93%
- 52W High
- $8.70
- 52W Low
- $6.23
- 50D MA
- $8.70
- 200D MA
- $7.54
- Beta
- 0.34
- Avg Volume
- 201
Get TickerSpark's AI analysis on APNHF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our APNHF coverage
Recent articles, reports, and earnings notes.
No research on APNHF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate APNHF report →Similar companies
Peers in the same neighborhood.